Pediatrics provides specialized medical care for infants, children, and adolescents. Learn about routine screenings, vaccinations, and treatments.

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors

Advanced Transcutaneous Technology and Spectral Analysis

Advanced Transcutaneous Technology and Spectral Analysis

The diagnostic evaluation of jaundice in newborns has been revolutionized by the advent of non invasive technology, specifically Transcutaneous Bilirubinometry. This method utilizes sophisticated spectral analysis to measure the optical density of bilirubin in the subcutaneous tissue. These devices emit light at specific wavelengths, typically blue and green, and analyze the reflection and absorption patterns to calculate a bilirubin index. This technology significantly reduces the need for painful heel sticks and provides immediate data, allowing for high-frequency monitoring and trend analysis without depleting the infant’s blood volume.

Newer devices use multiple wavelengths to adjust for differences in skin color, making readings more accurate for all babies. Ongoing improvements help account for how skin structure and hydration affect results. Tracking how quickly bilirubin levels rise over time gives a better picture of risk than a single measurement.

  • Multi wavelength spectral reflectance analysis algorithms.
  • Correction factors for epidermal melanin and hemoglobin interference.
  • Non invasive monitoring of bilirubin accumulation rate and velocity.
  • Reduction of iatrogenic pain and anemia resulting from frequent blood draws.
  • Assessment of optical path length variations in the neonatal dermis.
Icon LIV Hospital

Serum Biomarkers and Biochemical Profiling

PEDIATRICS

Although skin tests are useful for screening, the most accurate way to diagnose jaundice is by measuring total serum bilirubin in the blood. This test separates bilirubin into direct and indirect types to find the cause. High direct bilirubin may mean a liver or bile problem, which needs further testing. Accurate lab results are key for choosing the right treatment.

Advanced biochemical profiling also looks for specific markers of hemolysis. A reticulocyte count indicates if the bone marrow is responding to red blood cell destruction by releasing immature cells. A Coombs test (Direct Antiglobulin Test) detects antibodies attached to the infant’s red blood cells, diagnosing immune-mediated hemolysis such as Rh or ABO incompatibility. Additionally, End Tidal Carbon Monoxide monitoring is emerging as a precise breath test to quantify the rate of heme degradation. Since carbon monoxide is produced in a 1:1 ratio with bilirubin, this test provides a direct measure of bilirubin production independent of hepatic clearance mechanisms.

  • Fractionation of conjugated versus unconjugated bilirubin for etiological diagnosis.
  • Reticulocyte count for assessment of erythropoietic activity.
  • Direct Antiglobulin Test for diagnosis of immune-mediated hemolysis.
  • End Tidal Carbon Monoxide measurement for quantification of heme catabolism.
  • Peripheral smear analysis for red blood cell morphology and fragmentation.
Icon 1 LIV Hospital

Molecular Genetics and Precision Diagnostics

PEDIATRICS

For newborns with prolonged, recurrent, or unexplained Jaundice newborn, the diagnostic focus shifts to molecular genetics and genomic sequencing. Next-generation sequencing panels can identify mutations in the genes responsible for bilirubin conjugation and transport, such as the UGT1A1 gene for Crigler-Najjar and Gilbert syndromes or membrane transporter proteins associated with Dubin Johnson syndrome. This level of molecular precision allows clinicians to distinguish between benign physiological variants and pathological genetic disorders that may require lifelong management.

Testing for G6PD deficiency is also important, as this condition makes red blood cells more likely to break down under stress, causing sudden jaundice. Using genetic information helps doctors plan follow-up care and spot babies at risk for problems after leaving the hospital. This approach allows for earlier and more personalized care.

  • Next generation sequencing for UGT1A1 promoter and coding region mutations.
  • Screening for Glucose 6 Phosphate Dehydrogenase deficiency alleles.
  • Identification of organic anion transporter defects and membrane pathologies.
  • Analysis of alpha one antitrypsin phenotypes for metabolic liver disease.
  • Detection of hereditary spherocytosis membrane protein mutations.

Neuro Imaging and Functional Assessment

Molecular Genetics and Precision Diagnostics

If bilirubin levels are very high or there are signs of brain involvement, doctors may use MRI scans to look for changes in the brain linked to bilirubin toxicity. These scans can show where bilirubin has built up and caused stress in certain brain areas, helping guide treatment.

Functional assessment includes the Automated Auditory Brainstem Response (AABR). Since the auditory pathway and the cochlear nuclei are uniquely sensitive to bilirubin toxicity, this test is often the first indicator of neurotoxicity, even before overt motor symptoms appear. Failing an auditory screen in the context of severe jaundice triggers an urgent escalation of care to prevent permanent hearing loss. This neurodiagnostic approach aims to detect reversible cellular injury before it progresses to permanent kernicterus, acting as a functional biomarker of brain health.

  • MRI T1-weighted hyperintensity in the globus pallidus and subthalamic nuclei.
  • Automated Auditory Brainstem Response for assessment of pathway integrity.
  • Diffusion-weighted imaging for the detection of cytotoxic edema.
  • Proton magnetic resonance spectroscopy for analysis of metabolic ratios.
  • Visual Evoked Potentials for assessment of cortical processing.

Digital Health and Predictive Nomograms

Digital Health and Predictive Nomograms

Doctors now use digital tools and charts to assess jaundice risk. These tools compare the baby’s age and bilirubin level to set risk zones. Electronic health records can alert doctors if a baby’s levels are too high for their age or risk factors, helping ensure safe and consistent care.

This approach helps standardize care and makes sure babies who go home before jaundice peaks are checked again at the right time. Using digital alerts and apps keeps both doctors and parents aware of any risks, helping prevent serious complications.

  • Hour specific bilirubin risk stratification nomograms for discharge planning.
  • Automated clinical decision support alerts within electronic health records.
  • Integration of gestational age and risk factors into predictive algorithms.
  • Digital tracking of follow up compliance and readmission risks.
  • Predictive modeling for identifying infants at risk of severe rebound.

30 Years of
Excellence

Trusted Worldwide

With patients from across the globe, we bring over three decades of medical

Book a Free Certified Online
Doctor Consultation

Clinics/branches
Spec. MD. Demet Deniz Bilgin Spec. MD. Demet Deniz Bilgin Pediatrics
Group 346 LIV Hospital

Reviews from 9,651

4,9

Was this article helpful?

Was this article helpful?

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors

FREQUENTLY ASKED QUESTIONS

What is the difference between a skin test and a blood test?

The skin test uses a light sensor on the forehead and is painless. The blood test requires a small heel stick but provides a more precise measurement of bilirubin levels.

When blood cells break down, they release both bilirubin and carbon monoxide. Measuring the breath helps doctors see how fast the red blood cells are breaking down.

Conjugated bilirubin is the type that the liver has already processed. High levels of this type usually indicate a blockage or liver problem, not typical newborn jaundice.

No, an MRI is very rare and only used in severe cases. Doctors use it to check the brain only if they suspect high bilirubin levels have caused damage.

High bilirubin levels can temporarily affect the hearing nerves. A hearing test ensures the auditory system is functioning correctly after the levels return to normal.

Spine Hospital of Louisiana

Let's Talk About Your Health

BUT WAIT, THERE'S MORE...

Leave your phone number and our medical team will call you back to discuss your healthcare needs and answer all your questions.

Let's Talk About Your Health

Let's Talk About Your Health

Leave your phone number and our medical team will call you back to discuss your healthcare needs and answer all your questions.

Let's Talk About Your Health

How helpful was it?

helpful
helpful
helpful
Your Comparison List (you must select at least 2 packages)